73 related articles for article (PubMed ID: 15218827)
1. First drug for rare cancer.
FDA Consum; 2004; 38(3):4. PubMed ID: 15218827
[No Abstract] [Full Text] [Related]
2. Pemetrexed: current development and future directions in thoracic cancers.
Manegold C
Suppl Tumori; 2002; 1(4):S11-2. PubMed ID: 12415805
[No Abstract] [Full Text] [Related]
3. Positioning pemetrexed in the treatment of ovarian cancer.
Ledermann JA; Stebbing J
Eur J Cancer; 2009 May; 45(8):1330-2. PubMed ID: 19264477
[No Abstract] [Full Text] [Related]
4. Pemetrexed: new indication. Untreated non-small cell lung cancer: just another cytotoxic drug. No better than the gemcitabine-cisplatin combination with a different safety profile, as is the case for other cytotoxic drugs.
Prescrire Int; 2009 Jun; 18(101):114. PubMed ID: 19637425
[No Abstract] [Full Text] [Related]
5. [Expanded access program in the United States and Alimta program for malignant mesothelioma patients].
Nambu Y
Gan To Kagaku Ryoho; 2007 Feb; 34(2):284-6. PubMed ID: 17301544
[TBL] [Abstract][Full Text] [Related]
6. Pemetrexed in malignant pleural mesothelioma.
Hazarika M; White RM; Booth BP; Wang YC; Ham DY; Liang CY; Rahman A; Gobburu JV; Li N; Sridhara R; Morse DE; Lostritto R; Garvey P; Johnson JR; Pazdur R
Clin Cancer Res; 2005 Feb; 11(3):982-92. PubMed ID: 15709163
[TBL] [Abstract][Full Text] [Related]
7. Pemetrexed for the treatment of non-small-cell lung cancer.
Manegold C; Schmid-Bindert G; Pilz LR
Expert Rev Anticancer Ther; 2009 Sep; 9(9):1195-209. PubMed ID: 19761423
[TBL] [Abstract][Full Text] [Related]
8. FDA drug approval summaries: pemetrexed (Alimta).
Hazarika M; White RM; Johnson JR; Pazdur R
Oncologist; 2004; 9(5):482-8. PubMed ID: 15477632
[TBL] [Abstract][Full Text] [Related]
9. Pemetrexed: new drug. Pleural mesothelioma: a first encouraging trial.
Prescrire Int; 2005 Dec; 14(80):212-4. PubMed ID: 16400741
[TBL] [Abstract][Full Text] [Related]
10. [An atypical presentation of bronchial adenocarcinoma].
Langouo Fontsa M; Cstoth I; Berghmans T; Feoli F; Meert AP
Rev Med Brux; 2013; 34(3):181-3. PubMed ID: 23951859
[TBL] [Abstract][Full Text] [Related]
11. Novel therapeutic developments other than EGFR and VEGF inhibition in colorectal cancer.
Wilson RH
Oncologist; 2006 Oct; 11(9):1018-24. PubMed ID: 17030644
[TBL] [Abstract][Full Text] [Related]
12. Pemetrexed, a novel antifolate therapeutic alternative for cancer chemotherapy.
Villela LR; Stanford BL; Shah SR
Pharmacotherapy; 2006 May; 26(5):641-54. PubMed ID: 16637794
[TBL] [Abstract][Full Text] [Related]
13. [Second-line treatment of advanced non-small-cell lung cancer: role of pemetrexed].
Pérol M
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S14-7. PubMed ID: 16273004
[No Abstract] [Full Text] [Related]
14. [Pemetrexed: new multitargeted antimetabolite].
Lokiec F
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S5-7. PubMed ID: 16273001
[No Abstract] [Full Text] [Related]
15. Unsuccessful rechallenge with pemetrexed after a previous radiation recall dermatitis.
Barlési F; Tummino C; Tasei AM; Astoul P
Lung Cancer; 2006 Dec; 54(3):423-5. PubMed ID: 17049669
[TBL] [Abstract][Full Text] [Related]
16. [Medical treatment of malignant pleural mesothelioma. Role of pemetrexed in current treatment].
Margery J
Rev Pneumol Clin; 2005 Sep; 61(4 Pt 2):4S10-3. PubMed ID: 16273003
[No Abstract] [Full Text] [Related]
17. Efficacy and safety of pemetrexed in elderly cancer patients: results of an integrated analysis.
Kulkarni PM; Chen R; Anand T; Monberg MJ; Obasaju CK
Crit Rev Oncol Hematol; 2008 Jul; 67(1):64-70. PubMed ID: 18358737
[TBL] [Abstract][Full Text] [Related]
18. [Pemetrexed].
Sudoh J; Gemma A
Gan To Kagaku Ryoho; 2008 Jun; 35(6):1033-8. PubMed ID: 18633241
[TBL] [Abstract][Full Text] [Related]
19. Need for further information on pemetrexed study.
Aelony Y
J Clin Oncol; 2004 Oct; 22(20):4234-5; author reply 4235-6. PubMed ID: 15483040
[No Abstract] [Full Text] [Related]
20. The role of Alimta in the treatment of malignant pleural mesothelioma: an overview of preclinical and clinical trials.
Hanauske AR
Lung Cancer; 2004 Aug; 45 Suppl 1():S121-4. PubMed ID: 15261444
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
